Psorcast app analytics for December 14

Psorcast

Psorcast

  • Sage Bionetworks, a Not-For-Profit Research Organization
  • Apple App Store
  • Free
  • Medical
Why are we doing this research? People with psoriatic disease have told us that one of the worst parts about this disease is the uncertainty. There are looming questions about “When will this new therapy start working, and how long will it last?” or “Am I going to get psoriatic arthritis?” The Psorcast app is designed to understand psoriatic disease symptoms and how they change during the times between clinical visits. With a large open source data set, we aim to make, or help other scientists make, forecasts for outcomes like treatment effectiveness and development of arthritis. To find out more about the study, download the Psorcast app to explore and potentially join up as a participant. Who is doing this research? To accomplish the goals described above, the non-profit organizations Sage Bionetworks and PPACMAN (Psoriasis and Psoriatic Arthritis Clinics Multi-center Advancement Network) have partnered to create the pre-competitive Psorcast Consortium with industry partnership and funding from Novartis, UCB, Pfizer, and Janssen.
Psorcast

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

Psorcast Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for Psorcast

Rank

No Data Available

Psorcast Ranking by Country

Counties in which Psorcast has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

DERMNATION

DERMNATION

Blueprint NYC, LLC

Psoriasis Manager

Psoriasis Manager

At Point of Care, LLC

PDPA 2023

PDPA 2023

THANIGAIVELAN MUTHU

AAD 2024 Innovation Academy

AAD 2024 Innovation Academy

American Academy of Dermatology

Psorcast VS.

December 14, 2024